CERS Cerus Dashboard

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Company profile

Ticker

CERS

Exchange

NASDAQ

Website

www.cerus.com/

CEO

William Greenman

Incorporated

Delaware

Location

California

Fiscal year end

Dec 31

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Surgical & Medical Instruments & Apparatus

Boston Scientific • Baxter International • Becton, Dickinson And • 3M • Stryker • Teleflex • Resmed • Hill-Rom • Integra Lifesciences • Nuvasive ...

SEC CIK

0001020214

Corporate docs

Articles of Incorporation & Bylaws

IRS number

680262011

CERS stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

COVID-19 Convalescent Plasma Study Shows No Benefit, US NIH Stops Trial

3 Mar 21

The National Institutes of Health (NIH) has halted a trial evaluating the safety and effectiveness<

Cerus Q4 EPS $(0.09), Inline, Sales $33.60M Beat $32.42M Estimate

25 Feb 21

Cerus (NASDAQ:CERS) reported quarterly losses of $(0.09) per share which met the analyst consensus estimate. This is a 25 percent increase over losses of $(0.12) per share from the same period last year. The company

The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants

25 Feb 21

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 24)

Earnings Scheduled For February 25, 2021

25 Feb 21

Cerus Corporation And Shandong Zhongbaokang Medical Implements Partner To Establish Joint Venture In China To Commercialize The INTERCEPT Blood System; Cerus And Zhongbaokang To Be Sole Shareholders Of JV

24 Feb 21

Press releases

Pro users get this 30m faster

Cerus Corporation to Participate in Jefferies Virtual Global Plasma Summit

3 Mar 21

Cerus Corporation (NASDAQ:CERS) announced today that William ‘Obi' Greenman, Cerus' president and chief executive officer, and Kevin D. Green, Cerus' chief financial officer, are scheduled to participate in the

Cerus Corporation Announces Record Fourth Quarter and Full Year 2020 Financial Results

25 Feb 21

Cerus Corporation (NASDAQ:CERS) today announced financial results for the fourth quarter and year ended December 31, 2020. Recent developments and highlights include: Record total fourth quarter and full year 2020

Cerus Corp. to Host Earnings Call

25 Feb 21

NEW YORK, NY / ACCESSWIRE / February 25, 2021 / Cerus Corp. (NASDAQ:CERS) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 25, 2021 at 4:30 PM Eastern Time.To

Cerus Corporation and Shandong Zhongbaokang Medical Implements Partner to Establish Joint Venture in China

24 Feb 21

Cerus Corporation to Release Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021

11 Feb 21

Calendar

25 Feb 21

13 Apr 21

31 Dec 21

Financial summary

Financial statements Chart CERS financial data

Quarter (USD)	Dec 20	Sep 20	Jun 20	Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18	Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Cerus earnings reports.

Cash burn rate (estimated)	Burn method: Change in cash		Burn method: Operating income/loss		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	38.9M	38.9M	38.9M	38.9M	38.9M	38.9M
Cash burn (monthly)	(positive/no burn)	(positive/no burn)	4.78M	4.97M	2.82M	3.4M
Cash used (since last report)	n/a	n/a	16.52M	17.17M	9.74M	11.73M
Cash remaining	n/a	n/a	22.38M	21.73M	29.16M	27.17M
Runway (months of cash)	n/a	n/a	4.7	4.4	10.3	8.0

Beta Read what these cash burn values mean

Recent insider trades

CERS insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
15 Mar 21	Moore Carol	Common Stock	Sell	Dispose S	No	Yes	6.3777	7,989	50.95K	179,555
15 Mar 21	Moore Carol	Common Stock	Sell	Dispose S	No	Yes	6.3777	15,786	100.68K	164,774
15 Mar 21	Moore Carol	Common Stock	Sell	Dispose S	No	Yes	6.3777	5,556	35.43K	135,560
15 Mar 21	Menard Chrystal	Common Stock	Sell	Dispose S	No	Yes	6.3777	7,989	50.95K	105,853
15 Mar 21	Menard Chrystal	Common Stock	Sell	Dispose S	No	Yes	6.3777	15,786	100.68K	91,072
15 Mar 21	Menard Chrystal	Common Stock	Sell	Dispose S	No	Yes	6.3777	5,556	35.43K	61,858
15 Mar 21	Benjamin Richard J	Common Stock	Sell	Dispose S	No	Yes	6.339	20,000	126.78K	76,035
15 Mar 21	Benjamin Richard J	Common Stock	Sell	Dispose S	No	Yes	6.3777	7,989	50.95K	96,035
15 Mar 21	Benjamin Richard J	Common Stock	Sell	Dispose S	No	Yes	6.3777	15,786	100.68K	81,254
15 Mar 21	Benjamin Richard J	Common Stock	Sell	Dispose S	No	Yes	6.3777	5,556	35.43K	52,040

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2020

CERS institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

84.5% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	164	160	+2.5%
Opened positions	26	24	+8.3%
Closed positions	22	22	–
Increased positions	53	52	+1.9%
Reduced positions	51	51	–

13F shares	Current	Prev Q	Change
Total value	983.45M	3.09B	-68.2%
Total shares	142.11M	137.15M	+3.6%
Total puts	141.5K	315.5K	-55.2%
Total calls	417.4K	402.9K	+3.6%
Total put/call ratio	0.3	0.8	-56.7%

Largest owners	Shares	Value	Change
ARK Investment Management	29.57M	$204.64M	-1.4%
Baker Bros. Advisors	13.71M	$94.9M	0.0%
BLK Blackrock	12.38M	$85.66M	-8.9%
CMTDF Sumitomo Mitsui Trust	11.1M	$76.83M	+14.8%
Nikko Asset Management Americas	11.1M	$76.83M	+14.5%
Primecap Management	10.43M	$72.21M	-3.1%
Vanguard	8.68M	$60.09M	+4.1%
STT State Street	4.37M	$30.24M	-3.8%
Wasatch Advisors	2.96M	$20.49M	NEW
Geode Capital Management	2.67M	$18.46M	+4.5%

Largest transactions	Shares	Bought/sold	Change
Wasatch Advisors	2.96M	+2.96M	NEW
CMTDF Sumitomo Mitsui Trust	11.1M	+1.43M	+14.8%
Nikko Asset Management Americas	11.1M	+1.4M	+14.5%
Norges Bank	1.25M	+1.25M	NEW
Intrinsic Edge Capital Management	812.68K	-1.24M	-60.5%
BLK Blackrock	12.38M	-1.2M	-8.9%
Kennedy Capital Management	1.04M	-512.36K	-33.1%
Bamco	2.03M	+500K	+32.7%
ARK Investment Management	29.57M	-427.81K	-1.4%
MS Morgan Stanley	1.38M	+404.69K	+41.7%

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Grifols SA - ADR - Level III • Terumo • Grifols

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: absenteeism, Aid, alienate, anesthesiologist, attacked, batch, Biden, bleeding, Cadillac, Canadian, capture, career, caution, CCPA, CEO, certified, CFO, Chair, Chinese, choice, combating, conserve, consigned, consignment, constitutionality, CPRA, cultivate, culture, defense, delete, demographic, discrimination, disparate, distancing, distrust, emotional, empowered, entrepreneurial, ergonomic, EU, extra, extracting, fact, feedback, fibrinogen, fifteen, flexible, flu, foundation, fundamentally, gap, globe, guiding, hand, hemorrhage, HHS, home, ill, imperative, Importantly, influx, innovative, insolvent, intensified, ISO, JV, lab, laying, load, Louisiana, lowest, machinery, malware, manipulation, manual, mechanism, mental, mishandling, misleading, mission, Myelodysplasia, NaN, network, nonqualified, Northern, notably, NTAP, nurse, Occasionally, online, onsite, operationally, ordinary, pandemic, percent, perseverance, persist, pharmacy, physical, PRCFC, prerequisite, prescription, presidential, professional, progressing, prophylactic, ransom, recession, recognizable, recommence, reconfigure, reconfigured, reconsider, reexamining, rejected, remote, resource, restart, resubmit, resubmitting, resumed, resumption, resurface, resurge, resurgence, rigor, SA, salary, scalable, sequester, Shield, sickle, simple, slowdown, social, speculative, spike, Stifel, stipend, strategy, strive, striving, stronger, strongly, surge, surrender, Swissmedic, temporarily, thaw, thawing, tie, tone, traditional, transmit, truthful, turnover, unexercised, unnecessary, unprecedented, urgency, vaccination, vaccine, venture, version, Virginia, week, wellbeing, Wisconsin, women, word, workflow, workforce, workplace, workstation, worsen, worsened

Removed: absolute, accreted, adult, Aduro, automation, bargaining, Biotech, calculate, Chairman, claimed, collaborate, collective, conceived, consumed, contraction, deregulate, dilute, distributed, earning, eighteen, ending, exceeded, excise, FASB, flat, headcount, hostile, idle, imposing, inexperienced, installation, installment, jeopardize, jointly, lessee, Likewise, line, lump, Oxford, perquisite, pill, poison, practical, protocol, reclassified, reinvested, remained, reportable, Republic, resolution, seller, stated, straight, summarize, supervision, targeting, taxation, timeframe, Unaudited, unremitted, unsold, weak

From filing 10-K 2020 FY